Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Wednesday, July 30, 2025.
Arbutus Biopharma Corporation (NASDAQ:ABUS)
Long-Term Uptrend (+90) - ABUS is in a strong uptrend that is likely to continue. While ABUS is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid ABUS?
MarketClub looks at technical strength and momentum to determine if the timing is right for ABUS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for ABUS
The long-term trend has been UP since May 2nd, 2025 at 3.70
The intermediate-term trend has been UP since Jul 28th, 2025 at 3.36
The short-term trend has been UP since Jul 23rd, 2025 at 3.19
Smart Scan Analysis for ABUS
Based on our trend formula, ABUS is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 3.370 | 3.400 | 3.295 | 3.305 | -0.045 |
| Prev. Close | Volume | Bid | Ask | Time |
| 3.300 | 385429 | 2025-07-29 15:59:58 |
| Year High | 12.6 | Year High Date | 2018-08-02 |
| Year Low | 4.01 | Year Low Date | 2018-10-15 |
| 52wk High | 4.725 | 52wk High Date | 2024-09-09 |
| 52wk Low | 2.705 | 52wk Low Date | 2025-04-09 |
| Average Volume | 774,282 | Shares Outstanding | 191,527 |
| Market Cap | 103M | Assets | 117,010,000M |
| Liabilities | 37,853,000M | P/E Ratio | -3.08220000 |
| Volatility | 102.46 |